These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


520 related items for PubMed ID: 21675596

  • 1. Bihemispheric cerebral FDG PET correlates of cognitive dysfunction as assessed by the CERAD in Alzheimer's disease.
    Schönknecht OD, Hunt A, Toro P, Guenther T, Henze M, Haberkorn U, Schröder J.
    Clin EEG Neurosci; 2011 Apr; 42(2):71-6. PubMed ID: 21675596
    [Abstract] [Full Text] [Related]

  • 2. The functional neuroanatomy of verbal memory in Alzheimer's disease: [18F]-Fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) correlates of recency and recognition memory.
    Staffaroni AM, Melrose RJ, Leskin LP, Riskin-Jones H, Harwood D, Mandelkern M, Sultzer DL.
    J Clin Exp Neuropsychol; 2017 Sep; 39(7):682-693. PubMed ID: 27876444
    [Abstract] [Full Text] [Related]

  • 3. Reduced cerebral glucose metabolism in patients at risk for Alzheimer's disease.
    Hunt A, Schönknecht P, Henze M, Seidl U, Haberkorn U, Schröder J.
    Psychiatry Res; 2007 Jul 15; 155(2):147-54. PubMed ID: 17524628
    [Abstract] [Full Text] [Related]

  • 4. Executive deficits and regional brain metabolism in Alzheimer's disease.
    Woo BK, Harwood DG, Melrose RJ, Mandelkern MA, Campa OM, Walston A, Sultzer DL.
    Int J Geriatr Psychiatry; 2010 Nov 15; 25(11):1150-8. PubMed ID: 20069587
    [Abstract] [Full Text] [Related]

  • 5. Resting state glucose utilization and the CERAD cognitive battery in patients with Alzheimer's disease.
    Teipel SJ, Willoch F, Ishii K, Bürger K, Drzezga A, Engel R, Bartenstein P, Möller HJ, Schwaiger M, Hampel H.
    Neurobiol Aging; 2006 May 15; 27(5):681-90. PubMed ID: 15908048
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Functional neural correlates of figure copy and recall task performances in cognitively impaired individuals: an 18F-FDG-PET study.
    Han JY, Byun MS, Seo EH, Yi D, Choe YM, Sohn BK, Choi HJ, Baek H, Lee JH, Kim HJ, Woo JI, Lee DY.
    Neuroreport; 2015 Dec 02; 26(17):1077-82. PubMed ID: 26509549
    [Abstract] [Full Text] [Related]

  • 9. Morphological cerebral correlates of CERAD test performance in mild cognitive impairment and Alzheimer's disease.
    Dos Santos V, Thomann PA, Wüstenberg T, Seidl U, Essig M, Schröder J.
    J Alzheimers Dis; 2011 Dec 02; 23(3):411-20. PubMed ID: 21116054
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impaired cerebral glucose metabolism in prodromal Alzheimer's disease differs by regional intensity normalization.
    Küntzelmann A, Guenther T, Haberkorn U, Essig M, Giesel F, Henze R, Schroeter ML, Schröder J, Schönknecht P.
    Neurosci Lett; 2013 Feb 08; 534():12-7. PubMed ID: 23182881
    [Abstract] [Full Text] [Related]

  • 13. Neural correlates of delayed episodic memory in patients with mild cognitive impairment--a FDG PET study.
    Schönknecht OD, Hunt A, Toro P, Henze M, Haberkorn U, Schröder J.
    Neurosci Lett; 2009 Dec 25; 467(2):100-4. PubMed ID: 19819300
    [Abstract] [Full Text] [Related]

  • 14. Everyday cognition scales are related to cognitive function in the early stage of probable Alzheimer's disease and FDG-PET findings.
    Hsu JL, Hsu WC, Chang CC, Lin KJ, Hsiao IT, Fan YC, Bai CH.
    Sci Rep; 2017 May 11; 7(1):1719. PubMed ID: 28496183
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Longitudinal PET Evaluation of Cerebral Metabolic Decline in Dementia: A Potential Outcome Measure in Alzheimer's Disease Treatment Studies.
    Alexander GE, Chen K, Pietrini P, Rapoport SI, Reiman EM.
    Am J Psychiatry; 2002 May 11; 159(5):738-45. PubMed ID: 11986126
    [Abstract] [Full Text] [Related]

  • 19. Resting SPECT-neuropsychology correlation in very mild Alzheimer's disease.
    Nobili F, Brugnolo A, Calvini P, Copello F, De Leo C, Girtler N, Morbelli S, Piccardo A, Vitali P, Rodriguez G.
    Clin Neurophysiol; 2005 Feb 11; 116(2):364-75. PubMed ID: 15661114
    [Abstract] [Full Text] [Related]

  • 20. Assessment of mental deterioration with the Cognitive Abilities Screening Instrument (CASI) and glucose hypometabolism in Alzheimer's disease: the Osaki-Tajiri Project.
    Yamaguchi S, Meguro K, Ishii H, Meguro M, Akanuma K.
    J Clin Neurosci; 2009 Nov 11; 16(11):1430-4. PubMed ID: 19632119
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 26.